These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2881081)

  • 1. Skin reactions to long-term transdermal clonidine.
    Dick JB; Northridge DB; Lawson AA
    Lancet; 1987 Feb; 1(8531):516. PubMed ID: 2881081
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
    Hollifield J
    Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
    Breidthardt J; Schumacher H; Mehlburger L
    Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal antihypertensive therapy: clinical and metabolic considerations.
    Weber MA
    Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catapres-TTS: a two year posttrial followup.
    Kellaway GS; Lubbe WF
    N Z Med J; 1988 Jun; 101(847 Pt 1):380. PubMed ID: 2970607
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Polster AM; Warner MR; Camisa C
    Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transdermal clonidine: a new therapeutic approach in essential hypertension?].
    Groth H; Greminger P; Vetter H; Knüsel J; Baumgart P; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):265-9. PubMed ID: 3158058
    [No Abstract]   [Full Text] [Related]  

  • 10. Transdermal clonidine: therapeutic considerations.
    Sica DA; Grubbs R
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):558-62. PubMed ID: 16227779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal clonidine skin reactions.
    Prisant LM
    J Clin Hypertens (Greenwich); 2002; 4(2):136-8. PubMed ID: 11927798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin reactions to clonidine: not just a local problem. Case report.
    Crivellaro MA; Bonadonna P; Dama A; Senna G; Passalacqua G
    Allergol Immunopathol (Madr); 1999; 27(6):318-9. PubMed ID: 10611557
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 18. Rebound hypertension during initiation of transdermal clonidine.
    Stewart M; Burris JF
    Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension by a new transdermal form of clonidine.
    Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
    J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.